TNF and cancer: In addition, we calculated scores for 14 cancer-related pathways and showed that the PI3K pathway was enriched in the high-risk group, whereas the low-risk group had concurrent activation of oncogenic (WNT and MAPK) and immune pathways (TNFa and JAK-STAT) (Figure 8I).